COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00537355
Recruitment Status : Completed
First Posted : October 1, 2007
Last Update Posted : April 16, 2019
Information provided by (Responsible Party):
Dynavax Technologies Corporation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2008
Actual Study Completion Date : May 2008